Ending HCV: How Do We Get There From Here?

Slides:



Advertisements
Similar presentations
UNAIDS, Regional Support Team, Eastern and Southern Africa
Advertisements

HBV and HCV: America’s Hidden Epidemics Jeffrey Levi, PhD Trust for America’s Health October 14, 2010.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Treatment of AIDS in BRAZIL. ›Which nation has fared the best in response to the world’s Aids Epidemic? › It's not the United States; it's not China,
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
Malaria a story of ELIMINATION A partnership of:.
1 - InfoHep webinar, 25 April Prof Jeffrey V. Lazarus Editor-in-Chief, Hepatology, Medicine and Policy CHIP,
WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections Common structure Universal Health Coverage SDGs Cascade.
World Osteoporosis Day Love Your bones —Protect your future!
The HIV Response Where are we now?
Quick Review This presentation is the first in a series of presentations intended to familiarize you with disparities calculation Part I: YOU ARE HERE!
Contents - HIV global slides
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Interactive Workshop.
Hepatitis C Allies of Philadelphia August 2, 2017
Community Based Service Delivery Model
The Patient Experience With Systemic Lupus Erythematosus
Diabetic Dyslipidemia in Practice
Talking to Patients About HCV Treatment
Treatment Strategies in Mild to Moderate COPD
Managing Women Living With HIV Infection
Starting Strong: Initial Evaluation of the Patient With HCV
Improving the Diagnosis and Treatment of Seizures in Long-term Care
Initiatives in HIV.
Join the Ministerial Event on
HCV: Who Should We Screen and Why?
What does it take to reach the people who need it most?
Building Health Systems to Deliver People-centered Health Services
Overview of Disparities
World Health Organization Collaborating Centre for Occupational Health
HCV Care in Unique Patient Populations
The HCV Revolution: Are You and Your Practice Ready?
Generics – what can be done
Optimizing HIV Care By Guiding and Educating the Workforce
Best Practices in Screening and Linkage to Care in Hepatitis C Virus
HCV Screening.
Contents - HIV global slides
A Call to Action on Cryptogenic Stroke
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.
Improving Management of Type 2 Diabetes in Hispanic/Latino Patients
Community Advocacy for HCV: Identify, Link to Care, and Treat to Prevent.
Patrick Brenny, UNAIDS RST-WCA
Tackling Atopic Dermatitis
HIV Treatment: What Can You Do to Get and Keep Patients in Care?
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
CMV in the HSCT Recipient
AIDS-related deaths the lowest this century
Hidden Opportunities - What Will It Take to Reach in Eastern Europe?
Contents - HIV global slides
Challenges in Severe Asthma
Managing Age-Related Clinical Issues in Hemophilia
Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.
A Guideline-Based Approach to HCV Care
Challenges in LA SCCHN.
Hepatitis C Virus Diagnosis and the Holy Grail
Contents - HIV global slides
528,000 new cases 266,000 death 90 % of the deaths in LMIC
Strategies for Infection Control in Cystic Fibrosis
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Removing Barriers in the HCV Cascade of Care
Championing Evidence-Based Care in Patients With Acute Low Back Pain
HIV Among Gay and Bisexual Men and Other Men Who Have Sex With Men
MS, Age, and Immune Function
Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.
Monoclonal Antibodies in Migraine Prevention: What the Primary Care Physician Needs to Know.
Target-Setting, Impact and Resource Needs
Ask the Psoriasis Expert
Best Practices in Building HIV Care Networks
Presentation transcript:

Ending HCV: How Do We Get There From Here?

HCV: A Major Global Health Threat

The HCV Cascade of Care

Target Populations for HCV Elimination Focus on Treatment

WHO Global Strategy: Elimination, Not Eradication

We Have the Cure, but Is It Enough?

The HCV Cascade of Care It Starts and Ends With Prevention

HCV Elimination Is Possible Countries on Track for Elimination or Ahead

From Universal SVR to Elimination: How Do We Get There?

Our Ability to Cure HCV Infection in the Past Decade Has Created New Challenges

HCV Cascade of Care in the United Kingdom

HCV Infection in the United Kingdom

Path to Elimination of HCV Infection in the United Kingdom: Timeline

Path to Elimination of HCV Infection in the United Kingdom: Infrastructure for Reaching Everyone

Path to Elimination of HCV Infection in the United Kingdom: Equity of Access A Bureaucratic Approach That Is Working

HCV Cascade of Care in Germany

High HCV Infection Treatment Rates in Germany

Key Target Population in Germany: PWID

Key Target Population in Germany: Immigrants

Key Target Populations in Germany: Gay and Bisexual Men

HCV Infection in New Zealand

HCV Cascade of Care in New Zealand

Treating HCV Infection in New Zealand A National Strategy

Key Target Population in New Zealand: PWID

Path to Elimination of HCV Infection in New Zealand What Will It Take?

Gaps in Equity of Access to HCV Treatment

What Is New Zealand Doing About It?

What Is New Zealand Doing About It? (cont)

Concluding Remarks

Abbreviations